FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034057230> ?p ?o ?g. }

• W3034057230 endingPage "666" @default.
• W3034057230 startingPage "660" @default.
• W3034057230 abstract "Aims Chronic kidney disease (CKD) is associated with increased thrombotic events and seems to influence platelet reactivity. Conflicting results have been published on platelet response in CKD patients with stable coronary artery disease. The aim of our study was to investigate the impact of CKD on platelet aggregation in acute coronary syndrome (ACS) patients receiving dual antiplatelet therapy, included the more potent P2Y12 inhibitors. Methods We enrolled 206 patients with ACS, divided in two groups, according to the presence or the absence of moderate/severe CKD. Platelet aggregation was performed with light transmission aggregometry and results are expressed as percentage of maximum platelet aggregation. High residual platelet reactivity (HRPR) was defined as maximum platelet aggregation more than 59%. Results Patients with CKD [estimate glomerular filtration rate (eGFR) < 60 ml/min/1.73 m 2 , n = 28] were prevalent older, diabetic, had previous coronary revascularization. In these patients, platelet aggregation was significantly higher than in those with eGFR ≥ 60 ml/min/1.73 m 2 (ADP 10 μmol/l: 28.46 ± 26.19 vs. 16.64 ± 12.79, P < 0.001; ADP 20 μmol/l: 30.07 ± 25.89 vs. 17.46 ± 12.82, P < 0.001). HRPR was observed in 4.4% of patients, with higher prevalence in those with eGFR less than 60 ml/min/1.73 m 2 [21.4 vs. 1.7%, P < 0.001, odds ratio (OR) [95% confidence interval (CI)] = 15.91 (3.71–68.17), P < 0.001]. At multivariate analysis, after correction for baseline confounders, eGFR [adjusted OR (95% CI) = 0.95 (0.91–0.98), P = 0.007], together with the use of clopidogrel [adjusted OR (95% CI) = 23.59 (4.01–138.82), P < 0.001], emerged as determinants of HRPR. Conclusion In patients with ACS receiving dual antiplatelet therapy, CKD is associated with an increasing ADP-induced platelet aggregation and higher prevalence of HRPR, which is mainly correlated to clopidogrel use." @default.
• W3034057230 created "2020-06-12" @default.
• W3034057230 creator A5000659710 @default.
• W3034057230 creator A5006114131 @default.
• W3034057230 creator A5016439271 @default.
• W3034057230 creator A5017161547 @default.
• W3034057230 creator A5019606903 @default.
• W3034057230 creator A5021092874 @default.
• W3034057230 creator A5039949527 @default.
• W3034057230 creator A5052228022 @default.
• W3034057230 creator A5052896044 @default.
• W3034057230 creator A5068374739 @default.
• W3034057230 creator A5070579574 @default.
• W3034057230 creator A5078307107 @default.
• W3034057230 creator A5081032576 @default.
• W3034057230 creator A5082898748 @default.
• W3034057230 date "2020-06-09" @default.
• W3034057230 modified "2023-10-17" @default.
• W3034057230 title "Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome" @default.
• W3034057230 cites W101108198 @default.
• W3034057230 cites W1891044139 @default.
• W3034057230 cites W1972318620 @default.
• W3034057230 cites W1972679886 @default.
• W3034057230 cites W1978057575 @default.
• W3034057230 cites W1980315361 @default.
• W3034057230 cites W1999344982 @default.
• W3034057230 cites W2016046345 @default.
• W3034057230 cites W2032576629 @default.
• W3034057230 cites W2035495232 @default.
• W3034057230 cites W2085860529 @default.
• W3034057230 cites W2089286382 @default.
• W3034057230 cites W2099022345 @default.
• W3034057230 cites W2105397247 @default.
• W3034057230 cites W2108650851 @default.
• W3034057230 cites W2126009032 @default.
• W3034057230 cites W2133275623 @default.
• W3034057230 cites W2133991213 @default.
• W3034057230 cites W2144988859 @default.
• W3034057230 cites W2146130301 @default.
• W3034057230 cites W2149011208 @default.
• W3034057230 cites W2161744742 @default.
• W3034057230 cites W2162756930 @default.
• W3034057230 cites W2488868277 @default.
• W3034057230 cites W2530440392 @default.
• W3034057230 cites W2588873568 @default.
• W3034057230 cites W2622671544 @default.
• W3034057230 cites W2746833910 @default.
• W3034057230 cites W2752033985 @default.
• W3034057230 cites W2754054868 @default.
• W3034057230 cites W2756079456 @default.
• W3034057230 cites W2795726115 @default.
• W3034057230 cites W2796164561 @default.
• W3034057230 cites W2811072755 @default.
• W3034057230 cites W2899881514 @default.
• W3034057230 cites W2904156034 @default.
• W3034057230 cites W2923959372 @default.
• W3034057230 cites W52075394 @default.
• W3034057230 doi "https://doi.org/10.2459/jcm.0000000000000981" @default.
• W3034057230 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32520854" @default.
• W3034057230 hasPublicationYear "2020" @default.
• W3034057230 type Work @default.
• W3034057230 sameAs 3034057230 @default.
• W3034057230 citedByCount "7" @default.
• W3034057230 countsByYear W30340572302021 @default.
• W3034057230 countsByYear W30340572302022 @default.
• W3034057230 countsByYear W30340572302023 @default.
• W3034057230 crossrefType "journal-article" @default.
• W3034057230 hasAuthorship W3034057230A5000659710 @default.
• W3034057230 hasAuthorship W3034057230A5006114131 @default.
• W3034057230 hasAuthorship W3034057230A5016439271 @default.
• W3034057230 hasAuthorship W3034057230A5017161547 @default.
• W3034057230 hasAuthorship W3034057230A5019606903 @default.
• W3034057230 hasAuthorship W3034057230A5021092874 @default.
• W3034057230 hasAuthorship W3034057230A5039949527 @default.
• W3034057230 hasAuthorship W3034057230A5052228022 @default.
• W3034057230 hasAuthorship W3034057230A5052896044 @default.
• W3034057230 hasAuthorship W3034057230A5068374739 @default.
• W3034057230 hasAuthorship W3034057230A5070579574 @default.
• W3034057230 hasAuthorship W3034057230A5078307107 @default.
• W3034057230 hasAuthorship W3034057230A5081032576 @default.
• W3034057230 hasAuthorship W3034057230A5082898748 @default.
• W3034057230 hasConcept C126322002 @default.
• W3034057230 hasConcept C134018914 @default.
• W3034057230 hasConcept C156957248 @default.
• W3034057230 hasConcept C159641895 @default.
• W3034057230 hasConcept C164705383 @default.
• W3034057230 hasConcept C2777698277 @default.
• W3034057230 hasConcept C2778213512 @default.
• W3034057230 hasConcept C2778653478 @default.
• W3034057230 hasConcept C2993802102 @default.
• W3034057230 hasConcept C44249647 @default.
• W3034057230 hasConcept C49059817 @default.
• W3034057230 hasConcept C500558357 @default.
• W3034057230 hasConcept C555293320 @default.
• W3034057230 hasConcept C71924100 @default.
• W3034057230 hasConcept C89560881 @default.
• W3034057230 hasConcept C90924648 @default.
• W3034057230 hasConceptScore W3034057230C126322002 @default.

• next